MedTrace Logo

Intervention to Improve Coping With Negative Emotions in Patients With Psychosis (Feel-Good-Study)

NCT04592042 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2022-05-05

No results posted yet for this study

Summary

The aim of the present single-centered pre-post study is to assess the feasibility and to investigate the putative efficacy of an emotion-oriented group intervention for patients with psychosis. Patients with early psychosis in an inpatient unit receive a manualized group intervention focussing on emotional stability and emotion regulation (8 weekly sessions). Assessment will be performed at pre-therapy, post-therapy (after eight sessions and four weeks) and after a follow-up period of 12 weeks (8 weeks post therapy) and includes personal therapy goals and their realization, psychopathology, social functioning and emotion regulation skills as a putative mediator of change.

Conditions

  • Early Psychosis
  • Delusions
  • Emotional Distress
  • Self Esteem

Interventions

BEHAVIORAL

Feel-Good- Group

Eight sessions of group intervention focussing on information on emotion regulation, training of emotion regulation techniques and mindfulness.

Sponsors & Collaborators

  • Prof. Dr. Andreas Bechdolf (Chair of hospital), Vivantes Hospital Am Urban Berlin

    collaborator UNKNOWN

  • Prof. Dr. Nikola Stenzel (Collaboration partner), Berlin Psychological University, Berlin

    collaborator UNKNOWN

  • Dr. Karolina Leopold (Senior physician), Vivantes Hospital Am Urban Berlin

    collaborator UNKNOWN

  • Philipps University Marburg

    lead OTHER

Principal Investigators

  • Nikola M Stenzel, Ph. D. · Psychologische Hochschule Berlin

  • Andreas Bechdolf, MD · Vivantes Klinikum Am Urban, Berlin

  • Karolina Leopold, MD · Vivantes Klinikum Am Urban, Berlin

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
17 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-08
Primary Completion
2021-11-01
Completion
2022-01-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04592042 on ClinicalTrials.gov